Evaxion A/S

Evaxion A/S company information, Employees & Contact Information

Explore related pages

Related company profiles:

Evaxion A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology™. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology™, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology™ platform and vaccine pipeline, please visit our website.

Company Details

Employees
61
Founded
-
Address
Dr. Neergaards Vej 5f, Hørsholm,capital Region 2970,denmark
Email
in****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Hørsholm, Capital Region
Looking for a particular Evaxion A/S employee's phone or email?

Evaxion A/s Questions

News

ESMO: Evaxion hopes cancer vax data attract partner after cash crunch forces smaller phase 2 trial - Fierce Biotech

ESMO: Evaxion hopes cancer vax data attract partner after cash crunch forces smaller phase 2 trial Fierce Biotech

Evaxion Biotech expands AI-Immunology platform - TipRanks

Evaxion Biotech expands AI-Immunology platform TipRanks

Evaxion Biotech stock soars after MSD licenses its vaccine candidate - Investing.com

Evaxion Biotech stock soars after MSD licenses its vaccine candidate Investing.com

Evaxion offloads vaccine candidate to Merck for $592M biobucks - Fierce Biotech

Evaxion offloads vaccine candidate to Merck for $592M biobucks Fierce Biotech

Evaxion Biotech price target lowered to $6 from $35 at Lake Street - Yahoo Finance

Evaxion Biotech price target lowered to $6 from $35 at Lake Street Yahoo Finance

Evaxion Biotech to develop new vaccines for cancer - Pharmaceutical Technology

Evaxion Biotech to develop new vaccines for cancer Pharmaceutical Technology

Evaxion Biotech A/S Closes Public Offering Raising $10.8 Million to Advance AI-Powered Vaccine Pipeline - Nasdaq

Evaxion Biotech A/S Closes Public Offering Raising $10.8 Million to Advance AI-Powered Vaccine Pipeline Nasdaq

Evaxion Biotech Announces Closing of $27.6 Million - GlobeNewswire

Evaxion Biotech Announces Closing of $27.6 Million GlobeNewswire

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near? - Yahoo Finance

Evaxion Biotech A/S (NASDAQ:EVAX): Is Breakeven Near? Yahoo Finance

Evaxion Biotech A/S Expands Phase 2 Trial of Personalized Cancer Vaccine EVX-01 to a Three-Year Study Duration - Nasdaq

Evaxion Biotech A/S Expands Phase 2 Trial of Personalized Cancer Vaccine EVX-01 to a Three-Year Study Duration Nasdaq

Earnings call transcript: Evaxion Biotech’s Q2 2025 results reveal strategic advances - Investing.com

Earnings call transcript: Evaxion Biotech’s Q2 2025 results reveal strategic advances Investing.com

Evaxion Biotech Announces Pricing of Initial Public Offering - GlobeNewswire

Evaxion Biotech Announces Pricing of Initial Public Offering GlobeNewswire

Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end - Fierce Biotech

Merck bags options on Evaxion's AI-designed vaccines, offering small upfront and big back end Fierce Biotech

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit? - Yahoo Finance

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit? Yahoo Finance

Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - Nasdaq

Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity Nasdaq

Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline - Investing.com

Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline Investing.com

Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital - GlobeNewswire

Evaxion Biotech Secures Equity Financing of up to $40 Million from Lincoln Park Capital GlobeNewswire

Evaxion Biotech A/S Announces $10.8 Million Public Offering of American Depositary Shares and Warrants - Nasdaq

Evaxion Biotech A/S Announces $10.8 Million Public Offering of American Depositary Shares and Warrants Nasdaq

Earnings call transcript: Evaxion Biotech Q4 2024 sees improved financials - Investing.com

Earnings call transcript: Evaxion Biotech Q4 2024 sees improved financials Investing.com

Evaxion Biotech A/S Announces Executive Management Changes - GlobeNewswire

Evaxion Biotech A/S Announces Executive Management Changes GlobeNewswire

Chipmakers Recap: What risks investors should watch in Evaxion Biotech A S Depositary Receipt stock - Market Growth Summary & Weekly Watchlist of Top Performers - Trung tâm Dự báo KTTV quốc gia

Chipmakers Recap: What risks investors should watch in Evaxion Biotech A S Depositary Receipt stock - Market Growth Summary & Weekly Watchlist of Top Performers Trung tâm Dự báo KTTV quốc gia

H.C. Wainwright maintains Buy on Evaxion Biotech with $14 PT - Investing.com

H.C. Wainwright maintains Buy on Evaxion Biotech with $14 PT Investing.com

H.C. Wainwright reiterates Buy rating on Evaxion Biotech stock with $16 target - Investing.com

H.C. Wainwright reiterates Buy rating on Evaxion Biotech stock with $16 target Investing.com

Evaxion vaccine sold to MSD: "A historic moment for us" - medwatch.com

Evaxion vaccine sold to MSD: "A historic moment for us" medwatch.com

Evaxion Biotech - The Pharma Letter

Evaxion Biotech The Pharma Letter

Evaxion Biotech Expands Capital Through ADS Sales and Warrant Exercises - TipRanks

Evaxion Biotech Expands Capital Through ADS Sales and Warrant Exercises TipRanks

3 more biotechs look to cull, partner assets in hopes of forging ahead - Fierce Biotech

3 more biotechs look to cull, partner assets in hopes of forging ahead Fierce Biotech

Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak - GlobeNewswire

Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak GlobeNewswire

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today? - InvestorPlace

Why Is Evaxion Biotech (EVAX) Stock Up 30% Today? InvestorPlace

Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail

Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) The Globe and Mail

Evaxion Biotech and MSD complete initial phases of bacterial vaccine collaboration - BioWorld MedTech

Evaxion Biotech and MSD complete initial phases of bacterial vaccine collaboration BioWorld MedTech

Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update - MarketScreener

Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update MarketScreener

Evaxion chair keeps quiet about reason for possible firing of CEO - medwatch.com

Evaxion chair keeps quiet about reason for possible firing of CEO medwatch.com

Evaxion Biotech stock slides after pricing $10.8M securities offering - MSN

Evaxion Biotech stock slides after pricing $10.8M securities offering MSN

Evaxion Biotech Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - MarketScreener

Evaxion Biotech Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update MarketScreener

EVAX Stock Price and Chart — NASDAQ:EVAX - TradingView

EVAX Stock Price and Chart — NASDAQ:EVAX TradingView

Evaxion Biotech - Via Ritzau

Evaxion Biotech Via Ritzau

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders - Fierce Biotech

Biogen CMO Maha Radhakrishnan joins Sofinnova—Chutes & Ladders Fierce Biotech

H.C. Wainwright raises Evaxion Biotech stock price target to $16 on Merck deal - Investing.com India

H.C. Wainwright raises Evaxion Biotech stock price target to $16 on Merck deal Investing.com India

Evaxion co-founder takes step back from management, joins board - medwatch.com

Evaxion co-founder takes step back from management, joins board medwatch.com

Chutes & Ladders—Astellas shakes up leadership with 2 new C-suite execs - Fierce Biotech

Chutes & Ladders—Astellas shakes up leadership with 2 new C-suite execs Fierce Biotech

Fierce Biotech Layoff Tracker 2023: Reneo reduces workforce by 70%; Oxurion cuts staff down to 10 - Fierce Biotech

Fierce Biotech Layoff Tracker 2023: Reneo reduces workforce by 70%; Oxurion cuts staff down to 10 Fierce Biotech

Chutes & Ladders—Ayala sheds execs amid Advaxis merger - Fierce Biotech

Chutes & Ladders—Ayala sheds execs amid Advaxis merger Fierce Biotech

Evaxion Biotech Shares Jump Following MSD Vaccine Licensing Deal - MSN

Evaxion Biotech Shares Jump Following MSD Vaccine Licensing Deal MSN

Evaxion A/S (EVAX) Stock Price, News & Analysis - MarketBeat

Evaxion A/S (EVAX) Stock Price, News & Analysis MarketBeat

Top Evaxion A/S Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant